Literature DB >> 6110953

Differences in prognosis for boys and girls with acute lymphoblastic leukaemia.

H Sather, D Miller, M Nesbit, R Heyn, D Hammond.   

Abstract

In the period 1968--78, 3161 children were enrolled in six studies of acute lymphoblastic leukaemia by participating institutions of the Childrens Cancer Study Group. In the first two studies, which did not include central-nervous-system (CNS) prophylaxis in the treatment programme, the outcome for male and female patients was very similar. In the following four studies, which included radiation prophylaxis to the CNS, a difference in outcome favouring females appeared consistently. This difference began about 6--12 months after initial remission and was further accentuated by withdrawal of therapy. Some of these studies also included a randomised trial of duration of therapy, studying 3 versus 5 years of maintenance treatment. Analysis of these studies suggests that sex group has implications both for duration of treatment and for optimum central-nervous-system prophylaxis.

Entities:  

Mesh:

Year:  1981        PMID: 6110953     DOI: 10.1016/s0140-6736(81)92623-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  23 in total

Review 1.  Drug treatment of acute leukaemia. Current status.

Authors:  S M Donohue; C P Charlton
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

2.  Importance of 6-mercaptopurine dose in lymphoblastic leukaemia.

Authors:  J P Hale; J S Lilleyman
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

3.  Prognostic factors in childhood acute lymphoblastic leukaemia.

Authors:  J Armstrong; M Pomeroy; J J Fennelly; S Cahalane
Journal:  Ir J Med Sci       Date:  1990-02       Impact factor: 1.568

4.  Long term survivors following treatment of childhood acute lymphoblastic leukaemia during 1970-75.

Authors:  B M Carr; J P Rees; J B Healy; I J Temperley
Journal:  Ir J Med Sci       Date:  1988-01       Impact factor: 1.568

5.  Isolated testicular relapse in boys with acute lymphoblastic leukaemia: treatment and outcome.

Authors:  J Tiedemann; J M Chessells; R M Sandland
Journal:  Br Med J (Clin Res Ed)       Date:  1982-12-04

6.  Current management of childhood acute lymphocytic leukemia.

Authors:  H Ekert
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

7.  Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population.

Authors:  B Klemetsdal; B Straume; E Wist; J Aarbakke
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Is the testis a chemo-privileged site? Is there a blood-testis barrier?

Authors:  Dhiren S Dave; John T Leppert; Jacob Rajfer
Journal:  Rev Urol       Date:  2007

9.  Thiopurine methyltransferase activity in a French population: h.p.l.c. assay conditions and effects of drugs and inhibitors.

Authors:  E Jacqz-Aigrain; E Bessa; Y Medard; Y Mircheva; E Vilmer
Journal:  Br J Clin Pharmacol       Date:  1994-07       Impact factor: 4.335

Review 10.  An odyssey in search of a cure: the evolution of treatment of childhood acute lymphoblastic leukemia in the United Kingdom.

Authors:  V Saha; T Eden
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.